From the FDA to EMA and beyond, regulatory authorities worldwide are modernizing guidelines to foster innovation and patient-centricity in clinical trials. Behind this modernization are the dual intentions of eliminating hurdles to innovation and ensuring that clinical trial regulations are optimally designed to minimize risk to patients. Together, the changes regulators are making aim to accelerate the development of safe and effective drugs and devices.
As organizations adapt to these regulatory changes, what’s the role of clinical trial technology? Join Katie Kahn of Medrio for a discussion of how researchers can leverage their eClinical resources to reach the level of flexibility and efficiency that a rapidly shifting regulatory environment demands.
Product Marketing Manager, Medrio
Katie Kahn joined Medrio in 2015 bringing years of clinical trial experience. She is an expert in eClinical technology and the regulatory landscape affecting various industries in clinical research. Katie holds a B.Sc. from Keck School of Medicine at the University of Southern California, and is a proud San Franciscan.